Maternal Serum Homocysteine as a Severity-Linked Biomarker Across the Spectrum of Hypertensive Disorders of Pregnancy: A Prospective Observational Study
Cureus · 21.05.2026
DOI: 10.7759/cureus.109335 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cureus, erschienen am 21.05.2026. Verfasst von Mouli Nandi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Luton and Dunstable University Hospital, Luton, GBR. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynaecology, Luton and Dunstable University Hospital, Luton, GBR.
Zitieren
APA
Nandi, M., & Mondal, R. (2026). Maternal Serum Homocysteine as a Severity-Linked Biomarker Across the Spectrum of Hypertensive Disorders of Pregnancy: A Prospective Observational Study. Cureus. https://doi.org/10.7759/cureus.109335
Vancouver
Nandi M, Mondal R. Maternal Serum Homocysteine as a Severity-Linked Biomarker Across the Spectrum of Hypertensive Disorders of Pregnancy: A Prospective Observational Study. Cureus. 2026. doi:10.7759/cureus.109335
BibTeX
@article{Nandi2026,
author = {Nandi, Mouli and Mondal, Rana},
title = {Maternal Serum Homocysteine as a Severity-Linked Biomarker Across the Spectrum of Hypertensive Disorders of Pregnancy: A Prospective Observational Study},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.109335}
}
EUVIMED